"Suicidality significantly declined" among trans youth who receive hormone replacement therapy, a new study has found.

THURSDAY, Nov. 6, 2025 (HealthDay News) — Transgender women using estradiol for their transition don’t run an increased risk of heart attack or stroke, a new study says. In fact, their hormone ...

According to the U.S. Census Bureau, about 2.6 million Americans identify as transgender, meaning their gender identity is different from the sex assigned to them at birth. When transgender people ...

The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminizing hormone therapy. This is demonstrated by an ...

A person with folded hands resting on a banister. Source: Ümit Bulut/Unsplash Research reports a higher occurrence of eating disorders among transgender individuals. Transgender individuals report ...

A new study of the longest-acting form of injectable PrEP, lenacapavir, has shown no adverse interactions with hormone therapy for trans women and men. Marketed under the brand name Yeztugo by Gilead ...

A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.

Lenacapavir does not appear to cause any clinically significant effects in the pharmacokinetics of long-acting hormonal contraceptives or gender-affirming hormone therapy, according to a pair of ...